Clinical and Paraclinical Characteristics of Severe Bronchiolitis in Children From 2 Months to 12 Months at the Children's Hospital 1 in Ho Chi Minh City

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

51 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-08-01

Study Completion Date

2019-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Goal: The aim of this study is to determine the epidemiological, clinical, paraclinical characteristics and treatment of severe bronchiolitis at the Children Hospital N01 in 2001-2002.

Materials and method: in this cross-sectional study, specimens of 51 patients with severe bronchiolitis at the Children Hospital N01 from March, 1 st 2001 to February, 28th 2002 are described and analyzed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Hypophosphatemia and Bronchiolitis

NCT04814641

Hypophosphatemia Bronchiolitis

UNKNOWN

Bilevel Noninvasive Ventilation in Infants With Bronchiolitis Presenting With Apnea

NCT04408534

Bronchiolitis

UNKNOWN NA

Study the Diagnostic and Therapeutic Role of Flexible Bronchoscopy in the Patients Attending Assuit University Children Hospita

NCT07043309

Chest Disorder

NOT_YET_RECRUITING

Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis

NCT06558461

Acute Bronchiolitis

COMPLETED PHASE2/PHASE3

Respiratory Outcome of Infants With or Without Documented Wheezing During Bronchiolitis

NCT04811248

Wheezing Asthma in Children

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epidemiological, Clinical, Paraclinical Characterictics of Severe Bronchiolitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

mild to moderate bronchiolitis

Bronchiolistis patients without Prematurity (gestational age ≤36 weeks), Low birth weight, Age less than 12 weeks, Chronic pulmonary disease, particularly bronchopulmonary dysplasia (also known as chronic lung disease), Anatomic defects of the airways, Hemodynamically significant congenital heart disease, Immunodeficiency and Neurologic disease

severe bronchiolitis

Intervention Type BIOLOGICAL

Prematurity (gestational age ≤36 weeks), Low birth weight, Age less than 12 weeks,Chronic pulmonary disease, particularly bronchopulmonary dysplasia (also known as chronic lung disease), Anatomic defects of the airways, Hemodynamically significant congenital heart disease, Immunodeficiency, Neurologic disease

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

severe bronchiolitis

Prematurity (gestational age ≤36 weeks), Low birth weight, Age less than 12 weeks,Chronic pulmonary disease, particularly bronchopulmonary dysplasia (also known as chronic lung disease), Anatomic defects of the airways, Hemodynamically significant congenital heart disease, Immunodeficiency, Neurologic disease

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* children younger from 2-12 months present fever (usually ≤38.3ºC \[101ºF\]) ,cough, and respiratory distress (eg, increased respiratory rate, retractions, wheezing, crackles)
* preceded by a one- to three-day history of upper respiratory tract symptoms (eg, nasal congestion and/or discharge) \]
* Respiratory distress.